The Startup Using AI To Make Hearing Aids Better
In this week’s edition of InnovationRx, we look at Fortell’s efforts to make a better hearing aid, Abby…
EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro (“ClearPoint”), a global…
Weill Cornell Medicine receives federal grant to study new gene therapy for Alzheimer’s disease
The National Institute on Aging of the National Institutes of Health has awarded a five-year grant initially worth…
Synthetic Human Chromosomes Explained
IntroductionTechnologies enabling synthetic chromosomesApplications in research and medicineEthical and safety considerationsFuture outlookReferencesFurther reading From synthetic chromosomes and recoded…
This Week in Science: World’s Biggest Scorpion, a Whale Graveyard, And More!
This week in science: A world record, a world first, and much more! We start with a scorpion…
Renowned physician‑scientist to lead Houston Methodist’s cell and gene therapy research
Malcolm Brenner, an internationally recognized physician‑scientist renowned for his leadership in cell and gene therapy, has been tapped to lead…
Regeneron (REGN) Says EMA Accepted Review for Otarmeni Application
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now. On…
Pediatric experts reveal the 10 research areas set to shape child health
From gene therapy and AI to vaccines, nutrition, and cancer care, pediatric research leaders outline where the next…
Common gene in axolotls, mice and zebrafish may unlock human limb regrowth
Investigating a common gene in three very different species – axolotls, mice and zebrafish – scientists have discovered…
A mother’s 20-year quest fuels a startling Duchenne breakthrough
A year after the worst day of her life, Debra Miller received a voicemail she couldn’t quite make…
Single protein is key to treating a deadly genetic heart disease targeting young athletes
A research team at the University of California San Diego has discovered a novel and promising method of…
AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)
Durham, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated…